Mark Gergen

Mark Gergen

Chairman chez POSEIDA THERAPEUTICS, INC.

Fortune : 2 M $ au 31/03/2024

61 ans
Health Technology
Commercial Services
Consumer Services

Postes actifs de Mark Gergen

SociétésPosteDébutFin
POSEIDA THERAPEUTICS, INC. Chairman 01/02/2023 -
Director/Board Member 01/02/2018 01/02/2023
Chief Executive Officer 01/02/2022 01/01/2024
Director of Finance/CFO 01/02/2018 01/07/2020
President 01/07/2020 21/02/2022
Director/Board Member 24/08/2022 -
Independent Dir/Board Member 24/08/2022 -

Historique de carrière de Mark Gergen

Anciens postes connus de Mark Gergen

SociétésPosteDébutFin
HALOZYME THERAPEUTICS, INC. Chief Operating Officer 01/09/2016 29/09/2017
MIRATI THERAPEUTICS Chief Operating Officer 19/02/2013 16/09/2016
Investor Relations Contact 19/02/2013 08/01/2016
Corporate Secretary 19/02/2013 16/09/2016
Corporate Officer/Principal 01/05/2005 01/11/2012
Corporate Officer/Principal 01/07/2003 01/03/2005
Advanced Tissue Sciences, Inc. Director of Finance/CFO 01/06/1999 -
Corporate Officer/Principal - 01/05/2003
Corporate Officer/Principal - -
Corporate Officer/Principal - -
░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ - -
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ -

Formation de Mark Gergen

Minot State University Undergraduate Degree
The University of Minnesota Law School Graduate Degree

Statistiques

Internationale

Etats-Unis 14

Opérationnelle

Corporate Officer/Principal 6
Director/Board Member 3
Director of Finance/CFO 2

Sectorielle

Health Technology 9
Commercial Services 3
Consumer Services 3

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés liées

Sociétés cotées2
HALOZYME THERAPEUTICS, INC.

Health Technology

POSEIDA THERAPEUTICS, INC.

Health Technology

Entreprise privées9
Advanced Tissue Sciences, Inc.

Commercial Services

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Voir les connexions sociétés